Top Pharma Companies & Drugs in 2024: Merck’s Keytruda maintains top spot as Novo’s semaglutide nips at its heels

Data Compilation
#PharmaFlow

Pipeline Prospector March 2025: Trump’s FDA overhaul spooks biotech stocks; Roche, AbbVie, Novo ink obesity drug deals

Stock Recap
#PipelineProspector

Remeron, Avanza, Zispin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

48 API Suppliers, 20 USDMF, 15 CEP/COS, 8 JDMF, 11 EU WC, 10 KDMF, 13 NDC API, 20 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

20 Intermediate Suppliers

20 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

443 FDF Dossiers, 72 FDA Orange Book, 244 Europe, 36 Canada, 46 Australia, 22 South Africa, 23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 15MG, TABLET;ORAL - 30MG, TABLET;ORAL - 45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 15MG, TABLET, ORALLY DISINTEGRATING;ORAL - 30MG, TABLET, ORALLY DISINTEGRATING;ORAL - 45MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 5 Evonik, 4 Rochem International Inc, 20 SPI Pharma, 6 DKSH, 8 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 6 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Pramukh Pharmachem, 1 Zeal MediPharma, 1 ACG Worldwide, 8 Actylis, 2 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 29 BASF, 1 Clariant, 12 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 11 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 37 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 23 Roquette, 13 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

92 Fillers, Diluents & Binders, 54 Coating Systems & Additives, 39 Direct Compression, 38 Disintegrants & Superdisintegrants, 32 Taste Masking, 30 Thickeners and Stabilizers, 30 Granulation, 29 Controlled & Modified Release, 27 Solubilizers, 22 Chewable & Orodispersible Aids, 19 Lubricants & Glidants, 18 Film Formers & Plasticizers, 18 Co-Processed Excipients, 14 Topical, 14 Parenteral, 7 Emulsifying Agents, 7 Rheology Modifiers, 7 API Stability Enhancers, 5 Coloring Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 13 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 226 Regulatory FDF Prices, 2 Annual Reports

MARKET PLACE

13 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 Health Canada Patents

3 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 7 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
25/04/2025	Aspen API	Netherlands	ASPEN OSS BV	10457	MIRTAZAPINE	1993-08-30	Active	II	N/A
25/04/2025	Neuland Laboratories	India	NEULAND LABORATORIES LTD	16007	MIRTAZAPINE	2002-06-11	Active	II	N/A

Remeron, Avanza, Zispin

Remeron, Avanza, Zispin

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

48 API Suppliers

20 USDMF

15 CEP/COS

8 JDMF

11 EU WC

10 KDMF

13 NDC API

20 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

INTERMEDIATES

20 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

443 FDF Dossiers

72 FDA Orange Book

244 Europe

36 Canada

46 Australia

22 South Africa

23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 15MG

TABLET;ORAL - 30MG

TABLET;ORAL - 45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, ORALLY DISINTEGRATING;ORAL - 15MG

TABLET, ORALLY DISINTEGRATING;ORAL - 30MG

TABLET, ORALLY DISINTEGRATING;ORAL - 45MG

RELATED EXCIPIENT COMPANIES

1 Minakem

5 Evonik

4 Rochem International Inc

20 SPI Pharma

6 DKSH

8 Faran Shimi Pharmaceutical

8 Boai NKY Pharmaceuticals Ltd

1 Chynops Pharma

6 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

2 Pfanstiehl

1 Pramukh Pharmachem

1 Zeal MediPharma

1 ACG Worldwide

8 Actylis

2 Alcedo Pharmachem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

29 BASF

1 Clariant

12 Corel Pharma Chem

6 DFE Pharma

1 Finar

11 Gangwal Chemicals

5 Ideal Cures Pvt Ltd

4 Ingredion Pharma Solutions

37 Kerry

3 Kima Chemical

6 Lonza Capsugel

15 Microlex e.U

1 Nanjing Bold Chemical

1 NEWEDGE Overseas

2 Nomisma Healthcare

3 Novo Excipients

4 Pharmatrans-Sanaq

8 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

23 Roquette

13 Seppic

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

TABLET;ORAL - 45MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons